A director at Ausnutria Dairy Corp Ltd sold 30,053,000 shares at 0.000HKD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
Global Rally Losing Upside Momentum The global rally appears to be losing steam as the bearish rising wedge patterns we highlighted last week in the MSCI ACWI, ACWI ex-US, EM, and EAFE indexes ended up breaking down. Additionally, the aforementioned indexes and major indexes in Europe, Japan, and Hong Kong have been unable to break above longer-term resistance. While we believe global equities remain vulnerable to a pullback, some near-term consolidation is another possibility. For now we belie...
Global Equities Stumbling Again We continue to believe global equities (ACWI-US) are likely to test the recent low made on March 23, with an undercut of roughly 10% also in the cards. This expectation is supported by price action during prior major waterfall declines in past recessionary periods. It is also worth noting that 15-25% rallies are to be expected within bear markets -- potentially multiple. During 2001-2002 the S&P 500 had two 20-25% rallies, and both ended up failing and breaking t...
We examined RB's 3Q19 results for insights on the Chinese infant milk formula industry. RB cited falling infant birth rates and intensifying competition as the key factors for its revenue decline. However, we highlight that RB’s firm-specific execution problems are the key culprit, and as such we believe RB’s revenue decline is not broadly representative of the industry. RB admits that local brand manufacturers have been strong lately and have been winning market share. Maintain OVERWEIGHT o...
Domestic consumption remained robust even though the growth rate slightly decelerated – high-growth segments were F&B, movies and online sales of domestic brands. Macau traffic remained robust, but tourist spend per capita appears to be softening. Hong Kong visitors and business remain expectedly poor, given the latest events. Data is positive for the restaurant, movie and home appliances segments.
As we continue to expect market volatility, we maintain exposure to names that have resilient earnings or are expected to enjoy an earnings growth recovery, such as Ausnutria Dairy (1717 HK), CSPC (1093 HK) and Dongfeng Motor (489 HK), and add PICC P&C (2328 HK) to our BUY list.
Domestic consumption looks healthy with better monthly data points for sportswear and home appliances. For capital markets, we see some opportunistic IPO listings (Budweiser, Topsport) this month on elevated valuation multiples. In Hong Kong, the outlook for retail and tourism remains bleak with the Golden Week likely to lead to write-offs. For Macau gaming, traffic and bookings should remain robust during the Golden Week, but GGR is likely to be weak on continued VIP and premium-mass weakness.
Domestic consumption looks healthy with better monthly data points for sportswear and home appliances. Thus for capital markets, we see some opportunistic IPO listings (ie Budweiser, Topsport) this month on elevated valuation multiples. For Hong Kong, the retail and tourism outlook remains bleak with Golden Week likely to lead to write-offs. For Macau, traffic and bookings should remain robust for Golden Week, but GGR is likely to be weak given continued VIP and premium-mass weakness.
Dairy names reported in-line 1H19 results with sales on track with guidance while bottom lines were slightly ahead due to the positive impact from non-operating factors. Leaders continued to win market share via product innovation, brand investment and channel penetration. The recent raw milk upcycle, representing higher cost inflation, while we note other materials have gone down as well as mix-upgrade to more than offset higher price of milk. Maintain OVERWEIGHT on the sector.
We expect equity markets to stay volatile in September, given the lack of progress on the Sino-US trade talks. Moreover, the global economic slowdown has deepened, bringing further pressure to corporate earnings. Hence, for the month, we add names that have more resilient earnings or are expected to enjoy an earnings growth recovery. These companies are Dongfeng Motor, Sany Heavy Equipment Int’l, Tencent Holdings, Tian Lun Gas Holdings and Wuxi Biologics.
Blue Orca issued a follow-up report on 19 August. Aside from bringing up a new argument in relation to production tonnage, the remaining arguments are just further elaborations of arguments from their first report. Once again, management rebutted all points and offers complete data transparency going forward. Maintain BUY and target price of HK$16.00.
KEY HIGHLIGHTS CHINA Results CSPC Pharmaceutical Group (1093HK/BUY/HK$12.96/Target: HK$17.00) 1H19: Earnings grew strongly by 24.8% yoy; easing policy pressure. Inspur International (596 HK/BUY/HK$3.77/Target: HK$5.25) 1H19: Core profit in line; resilient growth from cloud service business. Minsheng Education (1569 HK/BUY/HK$1.35/Target: HK$2.00) 1H19: Results in line with expectations; one school consolidated, three more to go. Tongcheng-eLong (780 HK/BUY/HK$12.32/Target: HK$20.00) 2Q19: ...
CHINA Results CSPC Pharmaceutical Group (1093HK/BUY/HK$12.96/Target: HK$17.00): 1H19: Earnings grew strongly by 24.8% yoy; easing policy pressure. Inspur International (596 HK/BUY/HK$3.77/Target: HK$5.25): 1H19: Core profit in line; resilient growth from cloud service business. Minsheng Education (1569 HK/BUY/HK$1.35/Target: HK$2.00): 1H19: Results in line with expectations; one school consolidated, three more to go. Tongcheng-eLong (780 HK/BUY/HK$12.32/Target: HK$20.00): 2Q19: Strong GMV growth...
Ausnutria issued a detailed rebuttal in response to Blue Orca's allegations, providing both convincing answers and supportive data. Furthermore, representatives from the two largest shareholders, Citic Agri and Center Lab, defended the company in the subsequent conference call. In our view, most salient points against Ausnutria have been dispelled and we see no major issues in corporate governance. Maintain BUY and target price of HK$16.00.
KEY HIGHLIGHTS CHINA Results BOC Aviation (2588 HK/HOLD/HK$65.75/Target: HK$69.00) 1H19: Admirable earnings growth amid concerns over B737 Max exposure. China Fortune Land (600340 CH/SELL/Rmb26.05/Target: Rmb23.34) 1H19: income increases but higher cash flow pressure, downgrade to SELL. Chongqing Rural Commercial Bank (3618 HK/SELL/HK$3.94/Target: HK$3.65) 1H19: Earnings boosted by lower staff cost. Update Kingdee (0268 HK/NOT RATED/HK$7.61) Profit meets consensus, but market weigh on...
CHINA Results BOC Aviation (2588 HK/HOLD/HK$65.75/Target: HK$69.00): 1H19: Admirable earnings growth amid concerns over B737 Max exposure. China Fortune Land (600340 CH/SELL/Rmb26.05/Target: Rmb23.34): 1H19: income increases but higher cash flow pressure. Downgrade to SELL. Chongqing Rural Commercial Bank (3618 HK/SELL/HK$3.94/Target: HK$3.65): 1H19: Earnings boosted by lower staff cost. Update Kingdee (0268 HK/NOT RATED/HK$7.61): Profit meets consensus, margin under pressure due to cloud transf...
We highlight our analysts’ high conviction calls for August – Ausnutria Dairy (1717 HK), China Communication Services (552 HK), China Gas (384 HK), CNBM (3323 HK), CSPC (1093 HK), Huaneng Renewables (958 HK), Huifu Payment (1806 HK), and Sunac China (1918 HK). We also add CQRC (3618 HK), Microport Scientific (853 HK), and Nine Dragons Paper (2689 HK) to our SELL list.
We highlight our analysts’ high conviction calls for July – Ausnutria Dairy (1717 HK), China Gas (384 HK), China Communication Services (552 HK), CNBM (3323 HK), GAC (2238 HK), Huifu Payment (1806 HK), Sino Biopharm (1177 HK), Sunac China (1918 HK) and Tongcheng-elong (780 HK).
We attended Vitasoy’s analyst briefing last week looking for a read-across for the dairy sector. On the supply side, most input raw material prices are on a downtrend, led by price declines from sugar and packaging while raw milk prices have seen a single-digit increase. On the demand side, management observed strong demand for higher-quality products, but competition has heightened as well. All in all, these trends are positive for the dairy industry, so we maintain OVERWEIGHT on the dairy se...
Trade frictions and persistent efforts at China’s containment will soon erode the optimism over a dovish Fed and ECB. While China will also roll out policies to shore up economic confidence, there are near-term risks of a weaker renminbi and capital flight. In addition, China’s growth potential will fall if efforts at displacing China from the global manufacturing value chain persist. Hence, we see pressures for further EPS downgrades and prefer BUYing domestic exposure for 2H19.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.